These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21542993)
1. Clinical experience in the use of marginal donor hearts. Xie AN; Dong NG; Zhang KL; Xia JH; Xiao SL; Sun ZQ Chin Med J (Engl); 2011 Apr; 124(8):1185-8. PubMed ID: 21542993 [TBL] [Abstract][Full Text] [Related]
2. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors. Abuanzeh R; Hashmi F; Dimarakis I; Khasati N; Machaal A; Yonan N; Venkateswaran RV Eur J Cardiothorac Surg; 2015 Jan; 47(1):72-7; discussion 77. PubMed ID: 24699201 [TBL] [Abstract][Full Text] [Related]
3. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure. Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601 [TBL] [Abstract][Full Text] [Related]
4. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999. Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G Clin Transpl; 2003; ():89-100. PubMed ID: 15387100 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients undergoing transplantation with older donor hearts. Drinkwater DC; Laks H; Blitz A; Kobashigawa J; Sabad A; Moriguchi J; Hamilton M J Heart Lung Transplant; 1996 Jul; 15(7):684-91. PubMed ID: 8820784 [TBL] [Abstract][Full Text] [Related]
7. Functional and morphologic adaptation of undersized donor hearts after heart transplantation. Mather PJ; Jeevanandam V; Eisen HJ; Piña IL; Margulies KB; McClurken J; Furakawa S; Bove AA J Am Coll Cardiol; 1995 Sep; 26(3):737-42. PubMed ID: 7642868 [TBL] [Abstract][Full Text] [Related]
8. Basiliximab and heart transplantation in Hispanics: the experience in Puerto Rico. Banchs HL; Carro Jiménez EJ; González V; González Cancel IF; Quintana C; Calderón R; Altieri PI; Rivera C Bol Asoc Med P R; 2007; 99(3):191-6. PubMed ID: 19610574 [TBL] [Abstract][Full Text] [Related]
9. [Routine hormonal therapy in the heart transplant donor]. Zetina-Tun H; Lezama-Urtecho C; Careaga-Reyna G Cir Cir; 2016; 84(3):230-4. PubMed ID: 26259737 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for post-transplant low output syndrome. Fujita T; Toda K; Yanase M; Seguchi O; Murata Y; Ishibashi-Ueda H; Kobayashi J; Nakatani T Eur J Cardiothorac Surg; 2012 Sep; 42(3):551-6. PubMed ID: 22328624 [TBL] [Abstract][Full Text] [Related]
12. The role of anti-IL-2 receptor in high-risk kidney transplant patients. Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764 [TBL] [Abstract][Full Text] [Related]
13. Results with expanded donor acceptance criteria in heart transplantation. Forni A; Luciani GB; Chiominto B; Pizzuti M; Mazzucco A; Faggian G Transplant Proc; 2011 May; 43(4):953-9. PubMed ID: 21620025 [TBL] [Abstract][Full Text] [Related]
14. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Ardehali A; Esmailian F; Deng M; Soltesz E; Hsich E; Naka Y; Mancini D; Camacho M; Zucker M; Leprince P; Padera R; Kobashigawa J; Lancet; 2015 Jun; 385(9987):2577-84. PubMed ID: 25888086 [TBL] [Abstract][Full Text] [Related]
15. Effect of older donor age on risk for mortality after heart transplantation. Gupta D; Piacentino V; Macha M; Singhal AK; Gaughan JP; McClurken JB; Goldman BI; Fisher CA; Beltramo D; Monacchio J; Eisen HJ; Furukawa S Ann Thorac Surg; 2004 Sep; 78(3):890-9. PubMed ID: 15337016 [TBL] [Abstract][Full Text] [Related]
16. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584 [TBL] [Abstract][Full Text] [Related]
17. The impact of gender on heart transplantation outcomes: a single center experience. De Santo LS; Marra C; De Feo M; Amarelli C; Romano G; Cotrufo M Ital Heart J; 2002 Jul; 3(7):419-23. PubMed ID: 12189971 [TBL] [Abstract][Full Text] [Related]
18. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy. Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399 [TBL] [Abstract][Full Text] [Related]
19. Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University. Edwards NM; Rajasinghe HA; John R; Chen JM; Itescu S; Mancini DM Clin Transpl; 1999; ():249-61. PubMed ID: 11038644 [TBL] [Abstract][Full Text] [Related]
20. Normothermic ex vivo allograft blood perfusion in clinical heart transplantation. Koerner MM; Ghodsizad A; Schulz U; El Banayosy A; Koerfer R; Tenderich G Heart Surg Forum; 2014 Jun; 17(3):E141-5. PubMed ID: 25002389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]